Literature DB >> 2071822

Is prolactin playing a role in the regulation of catecholamine synthesis and release from male rat adrenal medulla?

M L Hernández1, R de Miguel, J A Ramos, J J Fernández-Ruiz.   

Abstract

Previous evidence allows one to suspect that prolactin (PRL) may be a physiological regulator of catecholamine (CA) synthesis and release in the adrenal gland of rodents. To explore this possibility, we studied the in vivo and in vitro metabolism and release of noradrenaline (NA) and adrenaline (A) in the adrenal gland of male rats. The study was carried out with animals exhibiting a moderate increase in plasma PRL levels induced by grafting of additional pituitaries or a severe hyperprolactinemia produced by diethylstilbestrol (DES)-induced pituitary hyperplasia. The latter animals exhibited a significant increase in adrenal weight, associated with decrease in tyrosine hydroxylase (TH) activity and in NA content. Moreover, the adrenal activity of phenylethanolamine-N-methyl transferease (PNMT) was decreased in DES-treated animals. Pituitary-grafted rats also displayed an increased adrenal weight, together with decreases in the activities of PNMT, catechol-O-methyl transferase and monoamine oxidase. These in vivo observations were followed by in vitro studies, which showed a decrease in the basal release of both CAs from incubated adrenals of DES-treated rats, with no changes in pituitary-grafted rats. In addition, exposure to PRL of the incubated adrenals of animals exhibiting normal PRL levels produced decreases in A release and storage and in TH activity. These observations allow us to conclude that: i) PRL appears to exert an inhibitory influence on the catecholaminergic activity in the adrenal gland; and ii) its effect seems to be exerted by a direct action on this gland.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2071822     DOI: 10.1007/BF03346789

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  28 in total

1.  Purification and properties of phenylethanolamine-N-methyl transferase.

Authors:  J AXELROD
Journal:  J Biol Chem       Date:  1962-05       Impact factor: 5.157

2.  Glucocorticoid regulation of prolactin receptors in kidneys and adrenals of male rats.

Authors:  S Marshall; H H Huang; G S Kledzik; G A Campbell; J Meites
Journal:  Endocrinology       Date:  1978-03       Impact factor: 4.736

Review 3.  The anterior pituitary-grafted rat: a valid model of chronic hyperprolactinemia.

Authors:  R A Adler
Journal:  Endocr Rev       Date:  1986-08       Impact factor: 19.871

4.  Regulation of adrenal and testicular prolactin receptors by adrenocorticotropin and luteinizing hormone.

Authors:  M Katikineni; T F Davies; K J Catt
Journal:  Endocrinology       Date:  1981-06       Impact factor: 4.736

5.  Effects of estrogen-induced hyperprolactinemia on endocrine and sexual functions in adult male rats.

Authors:  A Bartke; P C Doherty; R W Steger; W W Morgan; A G Amador; D C Herbert; T M Siler-Khodr; M S Smith; H G Klemcke; W C Hymer
Journal:  Neuroendocrinology       Date:  1984-08       Impact factor: 4.914

6.  Fetal adrenal VIP: distribution and effect on medullary catecholamine secretion.

Authors:  C Y Cheung; M A Holzwarth
Journal:  Peptides       Date:  1986 May-Jun       Impact factor: 3.750

7.  Effect of elevated prolactin levels on the synthesis and release of catecholamines from the adrenal medulla in female rats.

Authors:  J Fernandez-Ruiz; M Cebeira; C Agrasal; J A Tresguerres; A I Esquifino; J A Ramos
Journal:  Neuroendocrinology       Date:  1987-03       Impact factor: 4.914

8.  Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography.

Authors:  T Nagatsu; K Oka; T Kato
Journal:  J Chromatogr       Date:  1979-07-21

9.  Pharmacological characterization of adrenal paraneurons: substance P and somatostatin as inhibitory modulators of the nicotinic response.

Authors:  F Mizobe; V Kozousek; D M Dean; B G Livett
Journal:  Brain Res       Date:  1979-12-14       Impact factor: 3.252

10.  Adrenal catecholamine content: effects of congenital GH, PRL and TSH deficiency and of hormone replacement therapy in the male mouse.

Authors:  A Lewiński; A Bartke; A Esquifino; E Sewerynek; R W Steger
Journal:  Exp Clin Endocrinol       Date:  1986-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.